Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Asante Bio
AddedFeb 18, 2024
UpdatedJun 18, 2026
Asante Bio

Asante Bio

Angel

Asante Bio: Innovating osteoarthritis management and joint preservation with economical, effective green biopolymers.

HQ
Norfolk, VA, US
Founded
2021
Overview
Compare
Fundraising
Employees
Website

Asante Bio is a joint preservation company developing regenerative orthobiologic implants for osteoarthritis pain management and tissue restoration. Their innovative products focus on biomechanical load-sharing and force-distributing orthopedic devices, addressing unmet needs in orthopedics and sports medicine. The company operates at the intersection of surgeon experience, biology, and biomechanics, offering economical and effective green biopolymer solutions.

Based in Norfolk, Virginia, Asante Bio aims to revolutionize evidence-based and value-based care in joint preservation. Their approach leverages simplified manufacturing processes and advanced biomaterial solutions to create medically engineered products. The company's intense focus on native tissue restoration and joint preservation positions them as leaders in developing disruptive technologies for orthopedic applications.

Asante Bio - Similar Companies

BioPoly logo

BioPoly

biopolyortho.com

Articulate Biosciences logo

Articulate Biosciences

articulatebio.com

New Ortho Polymers logo

New Ortho Polymers

RevOrtho logo

RevOrtho

revortho.com

OsteoNovus logo

OsteoNovus

osteonovus.com

Bone Biologics logo

Bone Biologics

Flex Biomedical logo

Flex Biomedical

flexbio.com

Sparta Biomedical logo

Sparta Biomedical

spartabio.com

Bioventus logo

Bioventus

Aravis BioTech logo

Aravis BioTech

aravisbiotech.com

Biomimedica logo

Biomimedica

biomimedica.com

BiomedInnovations logo

BiomedInnovations

Hyalex Orthopaedics logo

Hyalex Orthopaedics

hyalex.com

BioStable Science & Engineering logo

BioStable Science & Engineering

biostable-s-e.com

ReLive logo

ReLive

relivebio.com

Asante Bio - Quick Facts

Who are Asante Bio's competitors?

Companies similar to Asante Bio include BioPoly, Articulate Biosciences, New Ortho Polymers and RevOrtho.

When was Asante Bio founded?

Asante Bio was founded in 2021.

Where is Asante Bio's headquarters located?

Asante Bio's headquarters is located in Norfolk, VA, US.

When was Asante Bio's last funding round?

Asante Bio's most recent funding round was for $256k (USD) in May 2022.

How much has Asante Bio raised to-date?

As of May 31, 2022, Asante Bio has raised a total of $256k (USD).

How many employees does Asante Bio have?

Asante Bio has 5 employees as of Feb 4, 2024.

Asante Bio - Classification

Industry
  • Hardware
Ownership
  • Private
Technology
  • Biotech
Geographic Exposure
  • United States
Customer
  • Consumers
  • Enterprise
Main Product
  • Medical Devices
Tags
  • Healthtech
NAICS
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
Show 9 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 330000Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
SIC
  • 3900Miscellaneous Manufacturing Industries
  • 5000Wholesale Trade-durable Goods
  • 5040Professional And Commercial Equipment And Supplies
  • 5047Medical, Dental, And Hospital Equipment And Supplies